Small Business Innovation Research Phase IIB Bridge Awards

by: Michael Saunders

The National Institutes of Health, otherwise known as NIH, is an agency that is operating within the Department of Health and Human Services.

The National Institutes of Health is the United States government's principal agency that is responsible for most of the country's biomedical and health-related research studies.

The mission of the NIH is to continuously obtain new information that would help prevent, detect, diagnose, and treat diseases and disabilities.

In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

The program is in conjunction with the long running Small Business Innovation Research (SBIR) Program of NIH. The purpose of the SBIR program is to facilitate the innovation of solutions to existing health challenges by aiding the commercialization of the technologies that have been developed by small business concerns.

  (continued...)

Small Business Innovation Research Phase IIB Bridge Awards
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

Rural Health Research Center Program
The Health Resources and Services Administration has recently established the Rural Health Research Center (RHRC) Cooperative Agreement Program in an attempt to substantially improve the amount of high-quality, impartial, policy-relevant research studies.

---

Cancer Education Grants Program
The National Cancer Institute has developed the Cancer Education Grants Program wherein it seeks to financially support innovative educational efforts that would contribute to the reduction of cancer incidences, morbidity and mortality rates; as well as the improvement of the quality of life of surviving cancer patients.

---

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

HIV Innovations for Improved Patient Outcomes for Priority Populations Program
The United States Agency for International Development in South Africa has recently established the HIV Innovations for Improved Patient Outcomes for Priority Populations Program wherein it intends to solicit applications coming from local organizations which are interested in heading the implementation of a five-year plan centered on the program in focus.

---